;acting as muscarinic receptors antagonists or beta2-adrenoreceptors agonists, as well as to pharmaceutical compositions based thereon and to therapeutic applications for preparing a medicine to prevent and treat diseases, such as asthma, chronic bronchitis, etc.;EFFECT: obtained are novel compounds of formula (I) having activity towards muscarinic receptors or beta2-adrenoreceptors.;13 cl, 5 tbl, 39 ex, 2 dwg"/>
公开/公告号RU2606121C2
专利类型
公开/公告日2017-01-10
原文格式PDF
申请/专利权人 KEZI FARMACHEUTICHI S.P.A.;
申请/专利号RU20130154590
申请日2012-06-07
分类号C07D401/12;C07D409/14;C07D413/12;C07D417/12;A61K31/4545;A61K31/4709;A61P11/06;A61P11/08;
国家 RU
入库时间 2022-08-21 13:23:47